CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- 424B5 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 424B5 Offering Prospectus
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 424B5 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B4 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 424B3 Offering Prospectus
Page 2 of 6 · 101 filings